These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas. Kumar PP; Patil AA; Syh HW; Chu WK; Reeves MA Cancer; 1993 Jun; 71(11):3726-31. PubMed ID: 8490923 [TBL] [Abstract][Full Text] [Related]
12. [Short- to mid-term evaluation of CT-guided 125I brachytherapy on recurrent or metastatic head and neck cancers]. Huang ZL; Li CX; Zhang FJ; Jiao DC; Wu PH; Zhang T; Wang JJ; Duan GF; Wu YX Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):321-4. PubMed ID: 19563709 [TBL] [Abstract][Full Text] [Related]
13. High activity iodine 125 endocurietherapy for recurrent skull base tumors. Kumar PP; Good RR; Leibrock LG; Mawk JR; Yonkers AJ; Ogren FP Cancer; 1988 Apr; 61(8):1518-27. PubMed ID: 3280113 [TBL] [Abstract][Full Text] [Related]
16. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiotherapy for the treatment of pituitary adenomas. Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455 [TBL] [Abstract][Full Text] [Related]